Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4059 Target Snapshot

Lysosomal alpha-mannosidase · SINGLE PROTEIN · Homo sapiens

57Compounds
53Assays
0Approved Drugs
43.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt O00754. Use UniProt O00754 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O00754 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lysosomal alpha-mannosidase as ChEMBL target CHEMBL4059, mapped to UniProt O00754. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lysosomal alpha-mannosidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL4059
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
O00754
Lysosomal alpha-mannosidase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lysosomal alpha-mannosidase is the right protein anchor across sources, using UniProt O00754 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLysosomal alpha-mannosidase
UniProt AccessionO00754
Component TypeProtein
Sequence Length1011 aa

Lysosomal alpha-mannosidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lysosomal alpha-mannosidase, mapped to UniProt O00754. Sequence length is 1011 aa.

Mapped IDO00754
Review nameLysosomal alpha-mannosidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase II
Assay Mix

Activity Type Distribution

IC5036.0
KI6.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL371197 8.0 IC50 10.0 Clinical
CHEMBL4465842 6.36 IC50 440.0 Preclinical
CHEMBL476926 6.3 IC50 500.0 Preclinical
CHEMBL476926 6.26 Ki 550.0 Preclinical
CHEMBL476343 6.12 IC50 750.0 Preclinical
CHEMBL4462117 5.66 IC50 2200.0 Preclinical
CHEMBL4475419 4.76 IC50 17300.0 Preclinical
CHEMBL4457217 4.71 IC50 19300.0 Preclinical
CHEMBL425723 4.63 Ki 23300.0 Preclinical
CHEMBL425723 4.6 IC50 25000.0 Preclinical
Distribution

pChEMBL Value Distribution

1
5.0
3
5.5
6
6.0
0
6.5
1
7.0
0
7.5
1
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

53
Total Assays
30
Tested Compounds
2
Assay Types
Binding — 52 assays, 30 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 33 16 5.1
assay format 15 0
cell-based format 2 7 5.1
subcellular format 2 7 5.1
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine